This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec 3;114(24):4914-5.

doi: 10.1182/blood-2009-10-246371.

Fine-tuning targeted therapy of CML

Affiliations

PMID: 19965702
DOI: 10.1182/blood-2009-10-246371

Free article

Comment

Fine-tuning targeted therapy of CML

Neil P Shah. Blood. 2009.

Free article

. 2009 Dec 3;114(24):4914-5.

doi: 10.1182/blood-2009-10-246371.

Author

Affiliation

¹ University of California, San Francisco, CA, USA.

PMID: 19965702
DOI: 10.1182/blood-2009-10-246371

No abstract available

PubMed Disclaimer

Comment on

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.
Müller MC, Cortes JE, Kim DW, Druker BJ, Erben P, Pasquini R, Branford S, Hughes TP, Radich JP, Ploughman L, Mukhopadhyay J, Hochhaus A. Müller MC, et al. Blood. 2009 Dec 3;114(24):4944-53. doi: 10.1182/blood-2009-04-214221. Epub 2009 Sep 24. Blood. 2009. PMID: 19779040 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems